High-income countries called on to share COVID-19 vaccines quickly

New York – The former Co-Chairs of the Independent Panel on Pandemic Preparedness and Response (IPPPR), Ellen Johnson Sirleaf, former President of Liberia, and Helen Clark, former Prime Minister of New Zealand, have expressed their deep concern at the slow pace of redistribution of COVID-19 vaccines from high income to low-income countries.

“The Independent Panel report recommended that high-income countries ensure that at least one billion doses of vaccines available to them were redistributed to 92 low- and middle-income countries by 1 September, and a further one billion doses by mid-2022”, President Sirleaf and Helen Clark said. “Ensuring that all those around the world most vulnerable to the impact of the virus, including healthcare workers, older people and those with significant comorbidities, can be vaccinated quickly is a critical step towards curbing the pandemic.”

The Co-Chairs noted that, to date, 99 million dose donations have been shipped via COVAX, out of which only 89 million have been shipped to the 92 Advance Market Commitment countries – far short of the one billion doses the Independent Panel has called for. “High-income countries have ordered over twice as many doses as are needed for their populations. Now is the time to show solidarity with those who have not yet been able to vaccinate their frontline health workers and most vulnerable populations. Reaching the goal of redistributing one billion doses by 1 September would be a vital step in protecting the five billion people aged 15 and over who live in low- and middle-income countries. The 600 million doses which have already been pledged now need to be delivered with urgency”, the Co-Chairs said.

The Co-Chairs also noted that there needs to be much more rapid action on increasing vaccine production in low- and middle-income countries. “Manufacturing capacity has to be increased and knowledge and technology shared in order to scale up production quickly. This pandemic has shown the global risks of locating the know-how and manufacturing facilities in just a handful of countries.”

“We welcome the announcement that a COVID mRNA vaccine technology transfer hub has been established in South Africa. More such announcements are needed. Low- and middle-income countries must be able to produce more of their own vaccines and thereby help increase in general the amount of vaccine available to the world”, the Co-Chairs said.

For more information, please contact secretariat@ipppr.org

Doses pledged to COVAX: https://www.gavi.org/sites/default/files/covid/covax/COVAX-Dose-Donation-Table.pdf

Source: World Health Organization

G20 Compact with Africa reaffirms commitment to securing Africa’s recovery from Covid-19 pandemic through private sector development and vaccine manufacturing

Participants of a G20 Compact with Africa meeting this week assessed Africa’s progress in fighting the Covid-19 pandemic. “We are meeting at a pivotal time in the relationship between Africa and the rest of the world,” said Italian prime minister Mario Draghi.

The Compact with Africa is a G20 initiative that promotes macroeconomic, business and financing reforms to attract more private investment in Africa, including in infrastructure.

The conference brought together heads of state of the 12 Compact members and institutional partners, including the African Development Bank and the International Monetary Fund (IMF). It involved strategy discussions around attracting higher inflows of foreign direct investment to Africa and the urgent imperative to develop vaccine manufacture capability on the African continent. Securing the continent’s recovery from the impacts of Covid-19 is one of the Compact’s near-term objectives.

Vaccine inequity was a recurring theme, and heads of state shared reforms that they had undertaken as part of the initiative. Closer international cooperation was urged to address climate change, debt levels and investment shortfalls.

President Cyril Ramaphosa of South Africa emphasized that “Africa will not be able to recover until Africans are vaccinated.” President Emmanuel Macron said France had committed to providing $10 million vaccine doses for Africa.

African Development Bank President Akinwumi Adesina said the African Development Bank had committed to investing $5 billion to support vaccine manufacturing across Africa, while World Bank President David Malpass highlighted vaccine financing programs set up in 54 countries, noting that more than half of these are in Africa.

African leaders expressed consensus on the need for vaccine self-sufficiency as a longer-term solution. President Nana Akufo-Addo of Ghana said there should have been lessons learned from Ebola. European Commission President Ursula von der Leyen drew attention to the initiative to develop mRNA technology in Africa across different regional hubs.

African Development Bank President Adesina referred to gains made by Compact members. “We have seen a lot of improvement in public private partnerships and in the cost and ease of doing business but also in terms of the companies that are investing in a lot of African countries.” He also underscored the African Continental Free Trade Area and its expected impacts.

Other constraints discussed included rising levels of debt and restricted fiscal space resulting from the pandemic. “The reduction of liquidity,” hit us hard,” said Egyptian President Abdel Fattah Al Sisi. Although Ghana sustained growth through 2020, President Akufo-Addo acknowledged that national debt had risen to 77.1% of GDP.

Many speakers noted that reforms were yielding results. The IMF’s Georgieva said that Compact countries outperform their peers. Ethiopia Prime Minister Abiy Ahmed said his country had stabilized its debt through prudent management and opened up its telecom sector for investment.

A virtual session held on the sidelines of the conference provided a forum for German and African private sector representatives to discuss investment opportunities on the continent.

The Conference also included a follow-up session that focused on how to overcome economic, skills and intellectual property constraints to developing domestic mRNA vaccine manufacture across Africa.

Source: African Development Bank

COVID Pandemic Dampens Africa’s Economic Growth

Three years ago, nearly every country in Africa agreed to be part of a continental free trade area intended to lower tariffs and boost economies. But the agreement has yet to be fully implemented because of restrictions stemming from the COVID-19 pandemic.

The World Bank says the Africa Continental Free Trade Area Agreement set up the largest free trade bloc in the world, and has the potential to pull 30 million people out of poverty.

The agreement reduces tariffs between African countries and, the World Bank says, could boost Africa’s combined GDP by $450 billion by 2035.

But those prospects may not materialize because many countries in Africa have yet to fully open their economies due to health restrictions to combat the spread of the coronavirus.

Kennedy Adede, founder of Shining Hope for Communities (SHOFCO), which works in poor neighborhoods in Nairobi, says the lack of employment opportunities has to be addressed.

“People are going through a lot of hardship, people are more scared of dying from hunger than dying from this virus and that has become a challenge. How do we solve that? That’s why this is not just about the vaccine alone,” Adede said. “It needs a multi-angle [approach] to fight this economically to ensure that we drive more jobs. If you think in Africa right now, the population of young people is scary and if they don’t trust what we are saying, then we are gone.”

Speaking at a recent webinar, John Nkengasong, director of the Africa Centers for Disease Control and Prevention, said that if Africa was better prepared to combat the pandemic, the free trade area would be flourishing.

“It’s really for us in public health to continue to make sure that we place the public health agenda at the center of political dialogues, at the center of the economic dialogue. Look at the damage the pandemic has caused to our continental aspiration for the continental free trade area. I will argue that without this pandemic, that whole aspiration, the developmental agenda would have been at a very different level today in the continent,” Nkengasong said.

Nearly 18 months into the pandemic, just 2.5% of Africa’s 1.3 billion people are vaccinated. The African CDC wants to vaccinate 60% of the population by the end of 2022.

The agency says Africa had received 123.5 million vaccine doses by mid-August. The continent secured the vaccine through bilateral agreements and COVAX, a global initiative that seeks to provide vaccine to developing countries.

African countries will also share some 400 million Johnson & Johnson vaccine doses, which are being manufactured in South Africa.

But Nkengasong says Africa is still not receiving enough vaccine.

“When COVID just started, it was very difficult for anyone in Africa to know somebody who has died of COVID but now is a common thing we know, and that is pushing that you see lines of people out there. So the first doses of vaccines that we supplied in the continent, some of those ended up in wastage because we were dealing with misinformation. The challenge we have now is that people are saying here we are with open arms, ready to get the jab, but the jabs are not there,” Nkengasong said.

Africa’s economy is still expected to grow 3.4% this year, but that’s of little consequence to the tens of millions who are struggling to find a steady income as the virus takes away jobs and lives.

Source: Voice of America

Covid-19: US ships more than 2 million more vaccines to Africa

WASHINGTON, Aug 27 (NNN-AGENCIES) — The United States is shipping more than two million doses of COVID-19 vaccines to Algeria, Ghana and Yemen, the White House said, boosting efforts to combat a third wave of the pandemic across Africa.

The shipments, which a White House official said would land before the end of this week, will be the first donated by the United States to all three countries. They come on the heels of recent deliveries to other countries on the continent, including Nigeria and hard-hit South Africa last month.

Taken from surplus in the US stockpile, 604,800 doses of Johnson & Johnson will go to Algeria, just over 1.2 million doses of Moderna to Ghana, and another 151,200 J&J doses to Yemen, said the official, who asked not to be identified.

All the shipments are being made through Covax, the distributor backed by the World Health Organization and the Gavi vaccine alliance.

President Joe Biden, who took office promising to focus on getting Americans vaccinated after suffering the world’s highest toll from coronavirus, has since expanded his goal to make the United States the vaccine “arsenal” internationally.

The “administration understands that putting an end to this pandemic requires eliminating it around the world,” the White House official said.

Biden has come under fire for authorizing Americans to get booster shots starting in September, but US officials say there is enough capacity, even while maintaining the flow of donations abroad.

The latest shipments will raise the total number of US shots delivered in Africa to more than 25 million, the official said.

Africa is in the grip of a third wave of infections and losing the race to mass vaccination.

Less than two percent of people across the continent are fully vaccinated, with some countries having to destroy unused shots because they lack the health infrastructure to administer them or have met strong vaccine hesitancy.

Ghana, with a population of around 32 million, was initially hailed as a model for coronavirus response, even using drones to deliver vaccines to remote areas. Ghana was also the first country to get vaccines through Covax in February.

However, less than three percent of the population is estimated to have been fully vaccinated. The Covid death toll of 982, reported to the World Health Organization, is believed to be underestimated due to lack of testing.

Algeria, which has close relations with Moscow and was an early recipient of Russia’s Sputnik V vaccine, is also struggling to get shots in arms. According to WHO figures, there have been 5,063 Covid deaths in the country of 43 million people.

There is a lack of reliable pandemic data from Yemen, already on its knees from war and poverty. The devastated nation of 30 million relies on vaccine donations but also suffers from threadbare healthcare infrastructure.

The White House says about 130 million doses have so far been distributed from the United States to 90 countries.

In addition to dipping into its surplus supplies, the US government has purchased 500 million Pfizer-BioNTech doses specifically for distribution to the African Union and 92 selected low-income countries. The United States also donated $2 billion to Covax.

Source: NAM NEWS NETWORK

African countries commit to ending all forms of polio at regional meeting

Brazzaville – Governments from the World Health Organization (WHO) African Region have committed to ending all remaining forms of polio and presented a scorecard to track progress towards the eradication of the virus. The commitments came at a dedicated meeting on polio at the Seventy-first WHO Regional Committee for Africa.

While the African Region was certified free of wild poliovirus one year ago following four years without a case, outbreaks of circulating vaccine-derived poliovirus (cVDPV) continue to spread. cVDPVs occur in communities where not enough children have received the polio vaccine. Cases increased last year in part because of disruptions to polio vaccination campaigns caused by COVID-19. Since 2018, 23 countries in the region have experienced outbreaks and more than half of the global 1071 cVDPV cases were recorded in Africa.

“As Chair of the African Union, I am determined to work with other countries to protect the gains of our monumental efforts against polio and finish the job against all forms of this disease in Africa. Only then, we will be able to say we delivered on our promise of a safer, healthier future for all our children,” said H.E. Félix Tshisekedi, President of the Democratic Republic of the Congo.

At the Regional Committee, countries discussed how they will begin implementing the new Global Polio Eradication Initiative (GPEI) 2022-2026 Strategy that was launched in June to urgently stop the spread of cVDPVs. The tools and tactics outlined in the Strategy to stop outbreaks include:

• Improving the speed and quality of outbreak response, including through the rapid deployment of surge staff from the WHO Regional Office for Africa to support countries as soon as outbreaks are detected.

• Further integrating polio campaigns with the delivery of essential health services and routine immunization to reach children who have never been vaccinated, help build trust with communities and improve uptake of the polio vaccine.

• Broadening the rollout of the novel oral polio vaccine type 2 (nOPV2), a new tool that could more sustainably end outbreaks of type 2 cVDPV, which are the most prevalent. To date, six countries in Africa have rolled out the vaccine with close to 40 million children vaccinated and no concerns noted for safety.

“The poliovirus disregards and defies borders. Its presence anywhere in our region is a threat to all countries. Togo is committed to working with our regional partners and acting with the urgency required to implement high quality polio campaigns and protect children across Africa. With collective action, we will defeat all forms of polio,” said Hon Professor Moustafa Mijiyawa, Togo’s Minister of Health and Public Hygiene and Universal Access to Health Care and the Chairperson of the Seventy-first session of the Regional Committee for Africa.

The scorecard presented at the Regional Committee will track indicators for implementation of timely, high-quality polio outbreak response, readiness to introduce nOPV2 as the new vaccine becomes eligible for broader use, strengthening routine immunization to close immunity gaps, and transitioning polio assets into national health systems in a strategic, phased approach. Ministers committed to regularly reviewing progress together on each of these indicators to ensure collective success in urgently finishing the job on polio and securing a polio-free future for every child across the region.

“Our success in ending wild poliovirus in the region shows what is possible when we work together with urgency. COVID-19 has threatened this triumph as governments worked hard to limit the spread of COVID-19, pausing some campaigns. However, we cannot waver, and with renewed vigour we can overcome the final hurdles that jeopardize our success. We have the know-how, but it must be backed by committed resources to reach all under-vaccinated communities and ensure that all children thrive in a world free of polio. Together, we can help the world achieve polio eradication,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

Almost 100 million African children have been vaccinated against polio since July 2020, after activities were paused due to the COVID-19 pandemic.

The Regional Committee also discussed how to accelerate the transition of polio infrastructure into countries’ health systems, so that it can continue to support immunization and disease surveillance once polio is eradicated. The polio programme has a history of supporting the response to emerging health threats in the Region, including Ebola and COVID-19, and half of polio surge staff are currently helping countries with COVID-19 surveillance, contact tracing and community engagement.

“We need increased political and financial commitment by governments and partners to walk the last mile towards ending all forms of polio,” said Dr Tunji Funsho, chair of Rotary’s National PolioPlus Committee, Nigeria. “We must reach more children faster and comprehensively to not only curb outbreaks swiftly, but to also scale up vaccination coverage and give children lasting protection against this preventable disease.”

Dr Moeti spoke during a virtual press conference today facilitated by APO Group. She was joined by Hon Professor Moustafa Mijiyawa and Dr Tunji Funsho. Also on hand to respond to questions were Dr Pascal Mkanda, Coordinator, Polio Eradication Programme, WHO Regional Office for Africa; Dr Richard Mihigo, Coordinator, Immunization and Vaccines Development Programme, WHO Regional Office for Africa; and Dr Thierno Balde, Team Leader, Operational Partnerships, WHO Regional Office for Africa.

Note to editors:

The WHO Regional Committee for Africa is the World Health Organization’s decision-making body on health policy in the African Region. It comprises of Ministers of Health or their representatives from each of the 47 Member States in the African Region.

The Global Polio Eradication Initiative is a public-private partnership led by national governments with six core partners – the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), UNICEF, the Bill & Melinda Gates Foundation and Gavi, the Vaccine Alliance.

For Additional Information or to Request Interviews, Please Contact:

Collins Boakye-Agyemang

Communications and marketing officer

Tel: + 242 06 520 65 65 (WhatsApp)

Email: boakyeagyemangc@who.int

Ben Winkel

Director, Communications, Global Health Strategies

Email: bwinkel@globalhealthstrategies.com

Tel: +1 323 382 2290

Source: World Health Organization

WHO Says COVID-19 Wave ‘Stabilizing’ in Africa

A World Health Organization official said Thursday that the third wave of the COVID-19 pandemic on the continent appeared to be stabilizing, but numbers of infections are still very high, with almost 248,000 new cases reported in the past week alone.

During a virtual briefing on the status of the pandemic in Africa, WHO Africa Regional Director Matshidiso Moeti said that 24 countries were seeing a resurgence of infections and that deaths were rising in eight countries.

She said, “This is a preventable tragedy if African countries can get fair access to the vaccines.”

Moeti said the good news was that 13 million doses of COVID-19 vaccines were administered in the past week, triple that of the previous week. She said many of the doses came from donations and sharing arrangements through the WHO-administered COVAX vaccine cooperative.

She said 117 million doses were due to arrive in Africa in the coming month. But to meet the goal of having at least 10 percent of the continent vaccinated by the end of September, she said, another 34 million doses will be needed.

The WHO Africa director urged nations with ample supplies to keep sharing doses. She said, “With international solidarity we can protect those at highest risk of COVID-19 in all countries in the world.”

She also encouraged African governments to ensure that staffing and financial resources were available when shots arrived “to get vaccines into the arms of our populations. No precious doses should be wasted.”

Source: Voice of America